Approximately 15% of non-mucinous epithelial ovarian cancer patients carry germline mutations in BRCA1 or BRCA2, and approximately 5–7% of ovarian cancer patients have somatic BRCA mutations. This evidence concerns the gene BRCA2 and ovarian cancer.